Poison on the plate: Markets see rise in fake food products : Recent raids by the Commissionerate Police are a pointer to the volume of fake food items flooding the markets.

BHUBANESWAR: You eat with your eyes first, goes an adage. But going just by the looks of it may prove fatal considering the extent of spurious food that have made their way into the open markets, particularly from Cuttack. The recent raids by the Commissionerate Police are a pointer to the volume of fake and sub-standard food items laced with chemicals flooding the markets. 

What are you consuming?

From ghee, honey, turmeric and chilli powders to tomato sauce and soya chunks, the food adulteration network runs deep. The products are prepared using harmful chemicals, colours and sold to unsuspecting consumers at cheaper rates. A report suggests that spurious ghee is a heady mix of palm oil, vanaspati and yellow chemical colour; honey is prepared using water, sugar and chemical colour. For turmeric powder, the adulterators use waste rice powder and non-edible synthetic yellow colour.

The list does not end here. Soya chunks are prepared using flour and ammonium bicarbonate (a levelling agent) that makes the dough light and airy besides, chilli powder is laced with non-edible aniline dyes. The innocuous ketchups that go into your noodles, rolls and fast food are prepared using cheap red, orange and green colours along with a mixture of pumpkin, potato and tomato paste. These sauces are easily available in the market and commonly used by street food vendors. 

Capital Hospital’s Department of Forensic Medicine and Toxicology (FMT) consultant Dr LK Behera says adulterated food can cause serious health hazards and lead to diseases like cancer. “Turmeric is often adulterated by mixing wood powder and can cause obstruction in the intestine while chemicals in food products can cause cancer, gastroenteritis, liver and skin diseases, and others,” he says. 

Profits First, Health Second

The trade of spurious food is booming and food adulterators make a profit of 200 per cent (pc) through the illegal trade as cost of production is cheap.For example, production cost of a kg of refined honey is Rs 200 but that of adulterated honey is only Rs 40 which though sells for Rs 140 per kg in the market, says a report by Commissionerate Police. Whereas pure honey costs Rs 300 a kg and has a profit margin of 15 pc, sale of spurious honey brings 100 pc profit.

Similarly, production of branded and popular tomato or chilli sauce would cost Rs 120 per kg but the spurious and low-quality costs only Rs 30. The genuine sauce costs Rs 160 per kg having a profit margin of 20 pc but the fake one is sold at Rs 70 per kg with an 80 pc profit margin.The production cost of pure turmeric and chilli powders is Rs 150 per kg and adulterated is Rs 70 per kg. Unadulterated turmeric and chilli powders are available for Rs 260 per kg with a profit margin of 20 pc and the spurious powders are sold for Rs 120 per kg having a profit margin of about 60 pc. 

Similarly, adulteration of clarified butter or ghee is equally profitable with the unscrupulous elements earning 40 pc profit from the business. Production of ghee costs Rs 300 per kg and a kg of the spurious stock can be prepared with just Rs 80. Pure ghee is available in the market between Rs 350 and Rs 500, the spurious counterpart is available at Rs 150 a kg.

When it comes to soybeans, production cost is Rs 60 per kg as compared to Rs 30 per kg for the unadulterated item. Soybeans are sold for Rs 80 per kg in the market with 15 pc profit margin as compared to Rs 50 for the adulterated product having 40 pc profit margin. “It’s the high profit margin which drives these spurious food manufactures to sustain,” says Cuttack DCP Prateek Singh who has gone after the adulterators in his area of operation.

The Market & Consumers

The recent raids show food adulteration mafia operates mostly out of Cuttack city and Jagatpur which are hubs of manufacturing consumer goods besides outskirts of the Millennium City where they can remain low-profile. The businesses have been flourishing as surveillance by Cuttack district administration as well as the municipal corporation is next to nothing.

The consumer base, though, is spread across the region and food class. Much of the low-standard food is consumed by caterers which use the cost advantage to save on spending. Fast food makers are a big consumer base too as they pay little attention to health and hygiene; nor do their buyers.

“These manufacturers also focus on suburban and rural landscape of neighbouring districts where quality of packaged food is never under scrutiny due to poor surveillance of Food Supplies and Consumer Welfare Department,” says an officer.

Last year, Commissionerate Police alone registered 21 cases against production of adulterated food items and arrested 25 persons arrested while seizing goods worth over Rs 7.36 crore. This means the overall business of such spurious food manufacturers run into  tens of crores rupees across the State, just going by the volume exposed by Twin City Police.

Intensifying Surveillance

The raids have led to alarm but also brought relief from people in general that adulterated food is being obliterated from the markets. Locals have urged police to continue raids at food manufacturing units to arrest the menace. Surveillance is the need of the hour, they said. Apparently, such illegal units continue to thrive due to complacence of the municipal corporations and district administrations. Consider this: Odisha scored only 53.15 pc in Food Safety and Standards Authority of India’s second State Food Safety Index in 2019-20. 

This index is based on performance of the State on five significant parameters – human resources and institutional data, compliance, food testing (infrastructure and surveillance), training and capacity building, and consumer empowerment. The Index is a dynamic quantitative and qualitative benchmarking model that provides an objective framework for evaluating food safety across all States/UTs. FSSAI states that states scoring below 60 pc score need a push. 

Keep an Eye on Prices

Cuttack-Bhubaneswar Police Commissioner Sudhanshu Sarangi has urged citizens to not compromise with price while buying food items as adulterated products cost less in open markets. People must inform police if they find the price of a food product to be surprisingly low. 

“Our raids will continue so that health is not a casualty. We have also requested Odisha Industrial Infrastructure Development Corporation to review the land allotment of the units found to be involved in manufacturing adulterated food items and take necessary action against them,” said Sarangi.
Food adulteration is conducted to alter the taste and quantity and can have serious impacts on an individual’s health. People must be alert,” Dr Behera cautions.

Reference:
By Asish Mehta
Express News Service

https://www.newindianexpress.com/states/odisha/2021/jan/08/poison-on-the-plate-markets-see-rise-in-fake-food-products-2247212.html

LET US WAKE UP TO THE FAKE MENACE : About 25% of pharmaceuticals in India are fake, counterfeits and sub-standard.

Do you know that over two-third of milk and milk products available in the market do not meet the standards laid down by the authorities?

India is known as the country of festivals. With our diverse culture and languages we celebrate numerous festivals, across states. We relish on sweets, and one important constituent of sweets is (adulterated) milk. Detergent, caustic soda, glucose, white paint, melamine and even urea are used for adulteration of milk. Khoya and Chhena, commonly used for the preparation of traditional festival sweets are made from this milk and further contaminated with starch and finally decorated with toxic aluminum foil, instead of pure silver, endangering the lives of millions.

Milk is also fed to infants and small children. Besides sweets, milk is also used for making curd, cream, Lassi, Chhachh, butter, ghee and many more products that are consumed by Indian in abundance, in their everyday life. According to market estimates, the demand for fluid milk is substantially higher than the production. To fill this gap, milk suppliers and companies resort to unethical practices. One can imagine the kind of impact the sub-standard milk may have on the health of people, threatening young lives and future generations.

Is adulteration limited only to milk? Unfortunately not!

Fake, counterfeit, substandard, you name it and we have mastered it, for across categories of products, in India.

I have some uncomfortable questions.

Why is India alleged to be a global manufacturing hub for fake and counterfeit products? Do fake, counterfeit and sub-standard products form a big portion of India’s domestic drug & food market and is it growing at an alarming pace? Is almost one third of India’s economy accounted for, by fake products?

Wonder if we have answers to such embarrassing questions or if someone ever bothered to find out the answers.

One such soul, who dedicated his life to addressing the fake menace is Suresh Sati 63 years old rustic from a small hamlet in Uttarakhand. As a crusader, he is passionately committed to take on fake, counterfeit and substandard products in India and abroad. He has been fighting the lone battle for more than four decades.

It pains him that the fakes have not spared even our kitchens. Household spices, tea leaves, coffee powder, edible oil & ghee, food grain & flour, sauces, juices, ice-cream and sweets are the most chosen food items that are adulterated.

How do these food products impact the health of Indian citizens?

For instance, the cancer cases in India had risen by over 324% during 2017-18, as per National Health profile, 2019 data. As per the WHO’s World Cancer Report, one in 10 Indian will suffer from cancer in their lifetime. Fake food, medicine, toys and other products may be one of the major contributors.

The other big concern is the manufacturing and easy availability of fake medicines to innocent and unsuspecting consumers. As per ASSOCHAM’s (Fake & Counterfeit Drug in India – Blooming Biz) Report, about 25% of pharmaceuticals in India are fake, counterfeits and sub-standard. Shockingly, the fakes are valuedat US$ 4 billion of the estimated US$ 14 -17 billion, domestic drug market.

Suresh likes to draw attention to news that largely got unnoticed. More than 10 people have died at India’s premier medical facility, AIIMS, New Delhi, due to AMR.

As the world struggles to handle the COVID pandemic (which is on decline as various vaccines are making their debut, across the world), we are facing an even bigger threat in AMR (Antimicrobial resistance), which unlike Covid, is totally an un-treatable disease. Is AMR the next big Killer?

AMR is believed to be precipitated by usage of fake drugs, especially antibiotics.

Besides impacting the health of people, fake products also have a strong adverse impact on the health of Indian economy.

Even as the FMCG Sector loses approx 15% of its revenue, overall Indian corporates lose about 30% of their business to fake, counterfeit and sub-standard products.

This also leads to substantial loss to exchequer and has harmful impact on consumers, who tend to lose trust in the brand ethos of even most trusted companies.

Our nation is fighting this menace for 5 decades and as per ASPA,  the annual loss of revenue to the Indian exchequer is estimated at Rs 1 Lakh Crore (USD $13 b).

The fake menace is spreading tentacles from Delhi & other big cities (which still is a dominant market) to small towns like Patna, Indore, Raipur, Ahmedabad, Kolkata, Hyderabad, Bangalore, Nagpur, Baddi, Mumbai, Assam, Siliguri and many others.

Is there no solution?

One needs the likes of Suresh Sati to rise to the occasion.

Having spent four decades with 1600 investigations and over 500 raids to his credit, the ace investigator Suresh had a huge change of heart when he came across one of the most painful incidents of his life. This was a turning point for him.

Once, while in Patna a few years ago, Suresh saw a lady cry hoarse as her husband, a labourer had just passed away in a hospital. Holding on to her three small children, she was wailing that she had sold her mangalsutra to buy medicine for her husband and hospital people had killed him. Suresh noticed a polythene bag she carried with leftover fruits and some medicines that were fake.

Suresh shares agonisingly, “This broke my heart. I was distraught with the helplessness of the whole thing. Petty greed of a fake medicine manufacturer had ruined a family of four, with the only break-winner of the family losing battle to such crime. There and then, I resolved to set up a social organisation that will address this menace, so that no one in future will have to suffer such fate.”

The turning point made Suresh Sati launch what is called The Fake Free India (FFI) with a clear vision – to see a fake free society and a healthy and prosperous world.

Suresh partnered with an equally passionate Pravash Mishra, a branding veteran from Odisha, who has made a living in Delhi by offering amazing creative solutions on top of the corporate and Public Sector Clients and in social work. They set up FFI as a non-profit organization committed to ignite awareness amongst masses and other stakeholders with an objective of eliminating fake and counterfeit products.

Subsequently, Sujit Kispotta and Arun Arora, both with strong corporate backgrounds in marketing and communications quit their comfortable corporate jobs and joined the bandwagon, out of their strong passion to serve the society.

With their passion and determination, the foursome together aspire to make India, the first fake free nation, globally.

Suresh puts it emotionally, “We are missionaries with the mission of spreading awareness to combat the impact of fake products, leading to Healthy People, Strong Economy, a Credible Nation and Prosperous World”

In the first phase, the FFI has chosen to focus on areas that impact the health, safety and life of people and India’s economy. This includes Medicines and Drugs, Milk and Dairy products, Grocery and Gourmet Foods, Baby Care products, Toys, Agriculture products – seeds, pesticides and fertilizers, Health and Personal Care products and Safety linked Automotive spare parts.

In the next phase, FFI will also venture into the areas of Home, Kitchen Appliances,  Electrical products, Cosmetic / Beauty products, Tobacco and Alcohol, Education Books and Intellectual Properties (Entertainment, Literature and Software etc.).

FFI is inducting young students at schools and colleges, as Pravash Mishra echoes, “Today’s youth needs to be educated on the impact of fakes, so that they can be the flag bearers of this noble campaign, tomorrow.”

FFI Warriors are a bunch of volunteers from various age groups, all ignited with passion to eradicate fakes.

The organisation also plans to align and work with all like-minded stakeholders from govt and non-govt bodies, who have a common vision, mission and passion.

With 40 years experience in addressing the fake menace, FFI offers a reservoir of information on the entire fake supply-chain, across the country. It is proud of its huge network of associates and whistle-blowers who report to FFI, on a real-time basis.

“FFI  is proud to provide advisory and customized solutions to corporates, authorities and the government. We can design and implement campaigns for consumers, authorities, regulators, trade bodies and the government. We also propose to conduct Training and Awareness campaigns (on print, AV and Social media platforms) and provide media & advocacy support”, shares Sujit Kispotta.

FFI works on Pentacle Transformational Methodology (PTM) in its mission to substantially reduce fakes at the grassroots levels, over the next few years. It proposes to take Policy Advocacy and Research initiatives, use Media and Social Media Engagement, Corporate and Brand Engagement, Intelligence Gathering & Sharing to finally achieve Consumer Empowerment, through Awareness Building.

FFI strongly believes that besides the role being played by policy makers, stakeholders, judiciary, legal groundskeepers and media, every Indian has a role to play, to make India a fake free nation.

Similarly Corporates, who are quite active on their CSR front, if they also devote some energies to address the issue of fake products, this will help safeguard their consumers and uphold and enhance their brand reputation.

“FFI is determined to offer a common strong and credible platform that will bring all stakeholders together to fight against fake and counterfeit, to make India a fake free, healthy and prosperous nation.” Arun Arora concludes.

Sources and references to the information used in the article, above:

a.   The Economic Times

b.   CSR Vision

c.   Outlook

d.   ASPA

e.   WHO

f.    WHO World Cancer Report

g.   The Times of India

h.   ASSOCHAM (Fake & Counterfeit Drugs in India – Blooming Biz) Report

i.     FICCI Report

j.    ET Brand Equity quoting KPMG & FICCI Report

k.   ASPA

l.     Outlook

https://indiacsr.in/let-us-wake-up-to-the-fake-menace/

Winning the battle against falsified anti-malarials is helping consumers make better decisions – Kwasi Boateng, USP Ghana

Background: When Fight the Fakes heard the great news of how the percentage of falsified anti-malarials had dropped from 31% in 2009 to 1.5-2% in 2018 in Ghana, we wanted to know more. USP Ghana country manager, Mr Kwasi Boateng tells how the work of many hands had led to achieving this great result.

The success in reducing falsified anti-malarials in Ghana was made possible thanks to the Food and Drugs Authority (FDA) in Ghana and the USAID Funded Promoting the Quality of Medicines Programme implemented by US Pharmacopeia (USP), partner in the Fight the Fakes campaign. Together they worked on the programme promoting access to quality medicines. The programme kicked off in 2009 when the partners started monitoring and supporting measures to increase access to good quality anti-malarials. According to WHO’s World malaria report 2017, there are around 10 million cases of confirmed malaria in Ghana and almost the entire population is at risk of contracting the disease. Therefore getting the real treatment rather than a fake one is essential and life-saving. Nine years ago, there was a one in three chances you might be taking a falsified anti-malarial, fast-forward nine years and our latest monitoring report shows the percentage of falsified anti-malarials to be less than 2%. This is hugely good news.

Testing for fake medicines is essential – It’s been a long personal journey. Between 2011 and 2015, I was the PQM country consultant working on the monitoring programme directly with Ghana’s FDA team. We actively contributed to the USP Medicines Quality Database, a great resource which gave the World Health Organizations (WHO) almost 30% of the cases used to analyze for the WHO study on substandard and falsified medicines.

In 2015, I started working on different USP projects, but thankfully, I could continue my work on quality medicines. My work allowed me to go with the team around the country to take samples from the medicines distribution channels, from warehouses, public and private hospitals, retail pharmacies, over the counter sellers, mission hospitals, basically across the whole medicines supply chain. In addition, we were able to take samples from the informal sector.

To test the sample, we would put it through what we call a three-level approach. The first level was the visual and physical inspection of the product to see whether we could identify anything that would suggest quality issues. We would especially look at the packaging and the information on it. The second level involved using a GPHF-Minilab which employed Thin-layer chromatography, Colorimetric methods, and a disintegration test to check the identity of drugs and their approximate content. And finally, the third level would determine drug quality according to the compendial standards of the Medicines Control Laboratory. Over the years we have adopted also other screening methods such as “True Scan” which helps identify the quality standards of the products, as well as CD3 – the Counterfeit Detection Device nr.3, developed by America’s FDA, as additional tools for the second level screening, which is mainly carried out on the field. We used all three methods to see how they could complement each other. When irregular samples were found recommendations were made to Ghana’s FDA management, to take the necessary regulatory actions. Although the FDA does not have prosecution power, they can still recall products and impose fines.

The way we see it is that there are two types of samples that need to be signaled to the FDA. If we find out that the active pharmaceutical ingredients (API) are missing from the samples it is considered that the medicines have been deliberately falsified. When substandard medicines are found this could be attributed to potential mistakes in the manufacturing. Worryingly, this was a common occurrence for locally manufactured medicines. To solve this, Ghana’s FDA has put in place a Good Manufacturing Practice (GMP) roadmap for the local manufacturers, giving them guidance and helping them to become compliant with international standards.

Capacity building helps secure gains for the future – What is very rewarding is that our work goes beyond testing. USP Ghana trains and builds capacity. The more competent regulatory staff are in dealing with quality medicine, the better it is for the patients and the health system to ensure that quality products reach them. To date, USP has trained around 320 medicine regulators as well as local manufacturers and academics in 40 countries of Sub Saharan Africa. We are looking at ways to ensure we have good regulators in the future. For this reason, we are looking at ways to build capacity when regulators are being schooled, before they get on the field. We have piloted a project along with the University of Ghana School of Pharmacy, where we introduced lessons to final year students. It was great to see the results of our work in Mauritius for instance, where they now have their own medicines regulatory laws. We have also carried out testing on behalf of the countries that do not have the capacity for it.

Part of the successful achievement of lowering the percentage of falsified anti-malarials in Ghana was that the regulators were willing to tackle these issues. USP stepping up to support this through capacity building will have also contributed to the success. Today, the will is spreading across Africa and tackling falsified anti-malarials and medicines more generally, is a key objective for the New Partnership for Africa’s Development (NEPAD) African Medicines Regulatory Harmonization programme. I have been working for the Regulatory Capacity Development sub-committee of NEPAD focusing on harmonizing the curricula for training of regulatory staff across Africa. In addition, USP is a key actor and the technical partner of the African Medicines Quality Forum that gathers the network of laboratories in Africa aimed at reducing substandard and falsified medicines together in Africa.

The story does not end here – Together with anti-malarials, antibiotics are amongst the most commonly reported substandard and falsified medical products. Substandard and falsified medical products contribute to antimicrobial resistance and drug-resistant infections. Tackling falsified antibiotics is a major issue on the public health agenda but it doesn’t command as much attention, because the focus of funding is on solving the 3 major global health pandemics of HIV, Tuberculosis and Malaria. HIV medicines are considered safe from substandard and falsified medicines because the treatments come through the Ghana AIDS Control Programme. Anti-retrovirals to treat the condition come through a safe channel secured by the Global Fund. What we can test are the specific antibiotics used to treat TB but unfortunately, we cannot extend the screening to all antibiotics. So, while a great deal has been done to address the public health challenge of falsified anti-malarials, there is still plenty of work ahead.

Staying vigilant – In the meantime, what can people do to protect themselves from falsified medicines: We need to be aware. In my experience, in Ghana I would say that there is a kind of invisible consent that there are fake medicines out there. The level of awareness among citizens is very difficult to quantify but I feel reassured because people talk about the problem despite not having much evidence for them to point to. Raising awareness further can help encourage people to procure medicines from licensed outlets, wholesalers, distributors, with granted authorization from Ghana’s FDA. There is a strong incentive also for local manufacturers to step up the quality of their medicines. I get the general feeling that people usually perceive that local manufacturers in Ghana produce medicine that are of lower quality than international brands. The threat of a local manufacturer being found out to have supplied poor quality medicines should increasingly become an incentive to do better, or risk losing its reputation and having consumers shun their products.

My agenda going forwards – We can support more awareness about falsified medicines, and further help eliminate them by using the WHO Medical Product Alert System and this is very rewarding. This system channels the notifications about suspicious medical products and further alerts other Member States about the potential dangers of that product on the market. Furthermore, I think that linking falsified medicines and pharmacovigilance could be interesting. Pharmacovigilance is the practice of monitoring the effects of medical drugs after they have been licensed for use, especially in order to identify and evaluate previously unreported adverse reactions. This goes on today without patients knowing. Many of the systems are in place, so it could be easy to add collecting information on falsified medicines.

What makes me happy is that consumers are increasingly making wise decisions that take into account the quality of products and manufacturers and regulators are increasingly showing that they want to do things right. I am confident about that future.

http://fightthefakes.org/stories/winning-the-battle-against-falsified-anti-malarials-is-helping-consumers-make-better-decisions-a-story-from-kwasi-boateng-usp-ghana-country-manager/

Secure Label Printer Launches Site that Educates and Supports International Brands

VeriTrace, Inc., a manufacturer of anti-counterfeit labels, tapes, seals and security documents, is excited to announce the launch of their new website. Designed to offer a user-friendly experience, the website includes improved navigation and industry-specific secure print solutions product pages.

“Our new website highlights the wide variety of security technologies and the expertise we offer to help brands: authenticate, track, trace, fight diversion, secure and provide visibility into their supply chains,” Robert Sherwood, VP of Security Programs, points out.

VeriTrace is becoming an industry leader by offering more than secure print products, they offer complete customized solutions. For instance, their use of intaglio print technology with pressure sensitive materials to create a label that can be applied directly to products or cartons and can be easily verified for authenticity. They can add several overt and covert print technologies that can be linked to a secure track and trace solution to create labels that will help combat counterfeiting of consumer products. With these multi-layered security solutions, VeriTrace strives to be a thought leader and resource for brands looking to secure their operations and supply chain.

VeriTrace owner, Bob Hakman, states “We are very excited about the new VeriTrace website as it not only discusses all our capabilities for security printing but provides a great avenue for our customers to communicate with us, and we with them, about their security needs. The new site also makes it easy for us to show new or enhanced security features and technologies as we work to expand our innovative product offerings to both governmental and industrial clients.”

In addition to print services, VeriTrace offers supply chain track and trace solutions. Track and trace software allows companies to make improvements throughout the entire production and distribution process. The platform enables manufacturers to recall defective products, implement quality assurance procedures, and minimize errors. In addition, track and trace offers a line of defense against counterfeiting and diversion by creating a transparent supply chain.

Along with secure labels, seals, and tapes; track and trace technologies offer a sophisticated multi-layered brand protection solution.

Users are invited to join VeriTrace’s mailing list to have industry news regarding the latest in secure print technologies delivered right to their inbox. Valuable anti-counterfeiting content will also be available on the site’s blog section.

About VeriTrace
VeriTrace offers a complete line of state-of-the-art anti-counterfeit and tamper/void solutions combined with unique security designs providing powerful brand protection tools. The company’s labeling and packaging experience guarantees quality, successful application, long life expectancy and achievement of program objectives. To learn more about their products and services, please visit veritrace.com.

https://www.prweb.com/releases/secure_label_printer_launches_site_that_educates_and_supports_international_brands/prweb15972154.htm

Fake malaria drug prompts warning to travellers

A medical case study, just published in medical journal The Lancet, serves as a stark warning of the dangers of buying medicines when travelling.

Doctors in Spain report in the journal how they treated a 28-year-old woman who became dangerously ill as a result of being sold a counterfeit malaria drug whilst travelling in Equatorial Guinea.

She had previously developed malaria three times when visiting the country and treated it on each occasion successfully using locally-sourced artesunate combined with another drug (sulfadoxine-pyrimethamine).

The drugs that the patient had purchased – supposedly Artesunat produced by Vietnamese company Mekophar – were sent to the London School of Hygiene and Tropical Medicine (LSHTM) for analysis and there confirmed to be fake, despite being sold in convincing packaging that, upon cursory inspection, appeared to be authentic (see image below).

Once treated with genuine artesunate, the patient recovered within three days and was discharged from hospital.

The report draws attention to several distinctive features on the packaging of the fake drugs, including spelling mistakes, according to the authors, from the Clinica Universidad de Navarra in Spain and the LSHTM.

It comes after a May 2012 review in The Lancet Infectious Diseases warned that up to a third of antimalarial drugs sold worldwide could be fake.

“Counterfeit and substandard antimalarial drugs can effectively kill people taking them in endemic areas,” they write in the report. “They may also have a role in the genesis of resistance, since some samples have been found to contain subtherapeutic quantities of artesunate.”

https://www.securingindustry.com/pharmaceuticals/fake-malaria-drug-prompts-warning-to-travellers/s40/a9026/?fbclid=IwAR2nFmxnL8FSF6knpYoonGhgIJtRg_xXiYhsVQAeKiDSW3A1-BO5Otradx0#.XFwoZFUzbcf

An AI-Based ‘Tag’ By This Indian Startup May Just Revolutionise The Fake Products Market

Trotting that fake designer bag? Don’t brag, because this artificial intelligence-based ‘tag’ by an Indian startup may just call you out. Exploring AI in a unique way, this one-year-old startup has brought some interesting offerings to eliminate counterfeit products in the market, which is one of the major challenges companies face today. With offices in San Jose and Pune, NeuroTags is proving to be a unique startup whose main product is their AI-based technology which completely eliminates counterfeiting of the branded physical goods using patent-pending digital technology and AI.

To explore more about how it exactly achieves the goal, Analytics India Magazine got in touch with Nitin Gupta, co-founder, CEO and CTO at NeuroTags, who started the company along with Yogesh Miharia and Abhishek Agarwal. While Gupta is an ex-tech manager and a security expert who has worked with IT giants like Yahoo, PayPal and eBay, Miharia holds a corporate experience of about five years and Agarwal brings in experience from startup ventures, having previously co-founded ShaadiAmantran and TapOnAir.

The idea of founding NeuroTags is as interesting as the product itself. Gupta says that they got the idea while watching a documentary about the rampant counterfeit market. “It made us realise how big the problem is and how badly it is affecting the market,” he said. After a thorough R&D, the team designed a foolproof technology called NeuroTags, which was officially launched in Jan 2018.

The 18-members strong startup has witnessed a remarkable growth in the last one year, having acquired eight companies in India and are in talks with few other global and Indian brands.

A Leader In Anti-Counterfeit Technology

The startup is all about eliminating counterfeiting of the branded physical goods, and the founders claim to be solving the problem of counterfeiting that currently stands at $1.6 trillion. “The aim is to help the manufacturers keep track of their products and save it from counterfeiting,” says Gupta. With the help of NeuroTags, companies can engage and connect with their end consumers in the offline world and also acquire their product interaction data.

The data collection and analytics by NeuroTags aim to change the landscape for the non-tech-savvy manufacturers to compete with the top technology equipped companies by providing a superset of authentication and patent-pending track and trace technology that uses AI.

“Our technology is very simple to integrate and the process of authentication can be done in user’s mobile and our backend server. Our tags do not need any circuit, processor or chip, thereby making our offerings quite economical,” shares Gupta.

Customised solutions for track and trace: The startup boasts an out-of-the-box integrated track and trace package to support billions of products. Manufacturers can track an item and monitor their product distribution, geolocation-wise over the map. This enhanced visibility of their supply chain helps in product distribution validation to prevent any leak. They also provide the dashboard for brands to see their inventory and validate the current stocks. This helps in preventing waste due to dead stock in many consumer goods companies.

How Does The Technology Work?

Gupta explains that NeuroTags provides algorithmically coupled tags, namely open and protected. The open tag is visible on the product and can be scanned by anyone with a smartphone to get the information about the product and an indication of authenticity with a certain probability.

Once a product is purchased, the buyer has access to the protected tag, which is protected by a scratch layer or is kept inside the product seal. After scanning the protected tag, the user gets the authenticity information with certainty making both the tags disabled. So that if someone tries to copy the tags, the next customer will come to know that the product has been counterfeited by scanning it.

The user may also avail warranty, loyalty and referral points after scanning this tag. The tags are connected, monitored and protected by algorithms and AI on the cloud servers in such a way that, if anyone tries to replicate the tags, it gets caught and the copied product gets invalidated.

Use Cases

The technology by the startup can be adopted by any sector that sells physical goods and at a very economical budget, such as pharmaceutical, electronics, fashion, cosmetics, wine & spirits, toys jewellery, auto parts and more.

“For instance, in the case of alcohol, a user can scan our supplied code and validate the authenticity of the product before purchasing. Our consumer engagement tag provides them the incentive to scratch and win loyalty points which leads to them registering with the brands and avail loyalty. To make use of their loyalty points they would buy again from the same brand.

Our UX is very engaging and intuitive to the end consumer and we are seeing engagements up to 20% compared to the industry standard of 0.5 to 2%.

How Is NeuroTags Unique?

Gupta is quick to enlist some of the key differentiating factors such as:

  • NeuroTags provides a set of integrated technology suites, such as anti-counterfeiting, consumer engagement, track and trace, Data analytics and BI. A brand can activate one or more suites at any time and pays only per-use.
  • Patent-pending technology that truly eliminates the Counterfeit in the most effective way.
  • Cost effective and gives end consumers the assurance that they are buying a genuine product
  • For brands, we provide complete end to end solution for their automated production lines
  • Flexible and easy to adopt by brands in their existing process
  • Helps collect the real-time offline user’s data which in turn helps in BI
  • Insights of product lines effectiveness
  • Insights on Geography/City wise effectiveness
  • Enable A/B testing of marketing in the offline world

Concluding Note

With such a unique offering, the team believes that they currently do not face any direct competition in the market as there is no such technology still available that provides exactly the same solution to counterfeiting. “While there are similar B2B products such as Sproxil, which are operating in particular sectors such as pharma and retail, there are no direct competitions”, shares Gupta.

Having said that they are growing at a fast rate, already having worked with some of the major brands in the country. “With our cost-effective and powerful solution, we see ourselves to be the market leader in helping the companies grow their revenues by eliminating their counterfeits from the markets”, says Gupta while signing off.

https://www.analyticsindiamag.com/an-ai-based-tag-by-this-indian-startup-may-just-revolutionise-the-fake-products-market/

Govt extends ban on import of milk products from China for four months

The government has further extended the ban on import of milk and its products, including chocolates, from China for four months till April 23 next year, according to a notification of the commerce ministry issued Monday.

“Prohibition on import of milk, milk products (including chocolates, chocolate products, candies, confectionary food preparations with milk or milk solids as an ingredient) from China is extended for a further period of four months, i.e. till April 23, 2019, or until further orders,” the DGFT said in a statement.

The ban was first imposed in September 2008 and later extended from time to time.

https://www.business-standard.com/article/economy-policy/govt-extends-ban-on-import-of-milk-products-from-china-for-four-months-118122400754_1.html

The health consequences of falsified medicines- A study of the published literature.

Abstract

OBJECTIVES:

To analyse and present the literature describing the health consequences of falsified medicines, focusing on mortality and morbidity, as well as the scale of the issue, the geographic extent, the medicines affected, and the harm caused at both the individual and population levels.

METHODS:

We searched for articles in PubMed, using pre-optimized keywords ‘(counterfeit OR fake OR bogus OR falsified OR spurious) AND (medicine OR drug)’. Searches up to February 2017 yielded 2006 hits, of which 1791 were full-length articles in English. Among them, we found 81 papers that qualitatively or quantitatively described 48 incidents in which falsified medicines caused patients to suffer serious adverse effects, injury, symptoms or death.

RESULTS:

The distribution of incidents was examined according to the economic status of the countries involved, regional location in the world, therapeutic category of the medicines, number of incidents and victims by year, and characteristics of the falsified medicines. Among the 48 reported incidents, 27 (56.3%) occurred in developing countries and 21 (43.7%) in developed countries. These incidents involved a total of approximately 7200 casualties including 3604 deaths.

CONCLUSIONS:

Despite the poor quality of much of the reported data, the results of this study indicate that all types of medications have been targeted for falsification, and falsified medicines have had a serious impact on the health of both adults and children worldwide, with similar numbers of incidents in developing and developed countries.

https://www.ncbi.nlm.nih.gov/pubmed/30291683?fbclid=IwAR27hs-RvbrHJFI7V3eoz3PHFom2EJEjlj-OAAyWqy8GF4KG8IhXTvod0Fg

Israel’s bid to solve India’s “billion-dollar” healthcare problem

Israel’s healthcare industry has been one of the top contributors to its export-driven economy. According to the annual industry report published by Israeli Advanced Technological Industries at the MIXiii-BIOMED-2018 conference in Tel Aviv, pharmaceutical and medical technology exports accounted for almost forty percent of the total high-tech exports from Israel. The report further says that on an average, as many as 131 companies were formed each year for the last decade (2008-17). However, the same report also mentions that nearly 65 companies ceased to operate each year during the same period due to various reasons. According to another report from the Israeli Export Institute, Israel’s life sciences and healthcare export declined by twelve percent in the first half of 2016. Clearly, the industry needs to find more long-term and viable export destinations to ensure that cutting-edge healthcare innovations are streamlined to the market.

A growing market with unmet medical needs:

Looking eastwards, India seems to be perfectly poised to provide a largely unexplored market. With a 1.28 billion strong population, rise in the frequency of lifestyle diseases and increasing spending capacity of the middle-class, more Israeli healthcare innovators should look towards India to solve the next “billion-dollar problem”. India is known to be an extremely price-sensitive market and only a third of the Indian population have some kind of medical insurance. These factors have made India an arduous market for cutting-edge technologies to penetrate. However, the Indian government recently rolled out an ambitious healthcare plan – The Ayushman Bharat (meaning “Long live India”), with an ambition to expand the base of insured families in India. The plan stipulates to provide medical insurance cover of up to $7,000 per year to eligible families. Thus the government will provide insurance companies the premium to cover the medical expenses of over 100 million families who would otherwise not be able to pay for their hospital expenses. This scheme is regarded to be the largest healthcare scheme of the world and would surely provide a financial cushion for Israeli and other global healthcare companies to help solve the pressing healthcare issues of millions of patients.

Technology adoption can aid in narrow the gap:

India’s healthcare sector is an $81.3 billion dollar industry and is growing at a rate of 17 percent, which is unprecedented in the country’s history. This spectacular growth is fuelled by multiple factors including the rise in population, increase in purchasing power, a thriving middle class, the rise of non-communicable lifestyle diseases and rapid adoption of modern healthcare technologies. According to ICICI Lombard, a top health insurance company, top fatal diseases in India include lifestyle diseases (cardiovascular, respiratory, diabetes, diarrhea), infectious diseases (malaria, tuberculosis, dengue), cancer and mental health (leading to suicide). Combined, these disease areas can contribute up to 65 percent deaths. India is also home of the second highest number of diabetic patients in the world after China. In addition, the Indian healthcare system is also plagued by an insufficient number of healthcare professionals, low penetration of medical insurance and operational inefficiencies. However, the ground is ripe for adoption of cutting-edge technologies in healthcare. The explosive growth in the penetration of mobile phone and internet in recent years have led to many home-grown healthcare startups to gather significant traction. In fact, from 2014 to 2017 the early stage digital health companies in India have attracted over $600 million in funding across roughly 200 deals. Service companies such as online pharmacies (Pharmeasy, Netmeds), digital health (Practo, Livehealth) and wellness (CureFit) dominated the funding landscape. However, there is an apparent gap for product companies that can provide solution pertaining to disease pre-screening, diagnosis, therapeutics, telemedicine, monitoring patient behavior, etc. Together these diseases represent actionable avenues for Israeli companies to approach the Indian healthcare market.

The road, however, is not all smooth:

There are, however, certain entry barriers that might hold back foreign companies to aggressively approach India.

Firstly, as mentioned previously, India is known to be a price-sensitive market. Despite being the fastest growing major economy, India has the lowest GDP per capita among the BRICS countries – less than a quarter of that of other countries. To aggravate the situation, there is a staggering inequality in the wealth distribution between the rich and the poor. Thus, Indians tend to gravitate toward inexpensive solutions. Indian healthcare value chain and operational model have evolved around keeping costs as low as possible. Companies might need to compromise on the sophistication of their solutions to make it economically attractive in India.
Secondly, one must understand that Indian geography and demography are incredibly diverse and complex. This requires companies to develop hyper-localized business models to succeed in India. For example, companies with early-screening solutions will have better chances to succeed in Delhi due to the presence of numerous Mohalla clinics (primary health center) across the city than say, neighboring Rajasthan.
Thirdly, India is notorious for complex and intimidating bureaucratic proceedings. However, many of the erstwhile procedures have been done away with. In January 2017, the Government of India introduced a new set of medical device regulations which have been hailed by the medical device community. Most notably, if a device has been granted sales license from either US, UK, Australia, Canada or Japan, it will no longer be required to undergo clinical trials in India.
Lastly, India is the home to one of the largest generic drug market and is a major exporter of generics all over the world. The market is supported by Indian drug and patent laws that make it challenging for branded drug companies to succeed. This is a major point that the Israeli biopharmaceutical industry should take note of.
The beginning of a growing synergy:

Israel is no stranger to the Indian healthcare industry. Joining the league of defense, agriculture, and water technology, healthcare has become a major area of focus between the two countries over the years with quite a few success stories. Earlier this year, an Israeli startup – GlucoMe entered into an exclusive agreement with Apollo Sugar, a part of India’s largest chain of multispeciality hospitals to integrate its wireless blood sugar monitoring kit into Apollo’s home-care kit. In 2017, Zebra Medical Vision collaborated with Bangalore-based Teleradiology Solutions to employ’s Zebra’s proprietary deep learning analytics on radiology data to multiple healthcare centers across India. Both governments have taken pro-active roles to boost collaboration in the healthcare sector. Such initiatives, including the India-Israel Innovation Fund, numerous hackathons such as the TechEmerge challenge, aim to help Israeli startups launch pilot studies in India with the help of an Indian partner.

Envisioning brighter prospect, many Indian commercial firms are actively scouting for innovative Israeli startups which can potentially offer solutions to India’s healthcare challenges. Nuveos Tech LLP, co-founded by brothers Harit and Rishit Agrawal, seeks to bridge the gap between Israeli innovators and Indian consumers. “We form strategic partnerships with medical device companies. We not only provide access to the Indian market but also innovate the sales and distribution channels to the last mile” says Harit. Towards this end, the Mumbai based firm is already working with multiple Israeli companies. Recently, they signed a strategic agreement with Kfar-Saba based Healthwatch Ltd. to commence large-scale clinical trial for their wearable cardiac diagnostic device, Master Caution. “Along with the recent strong political and economic ties between the two countries, we believe this is a great opportunity” Agrawal brothers added.

https://blogs.timesofisrael.com/israels-bid-to-solve-indias-billion-dollar-healthcare-problem/

Tens of thousands die in Africa each year due to fake drugs

DAKAR (Reuters) – When Moustapha Dieng came down with stomach pains one day last month he did the sensible thing and went to a doctor in his hometown of Ouagadougou, Burkina Faso’s capital.

The doctor prescribed a malaria treatment but the medicine cost too much for Dieng, a 30-year-old tailor, so he went to an unlicensed street vendor for pills on the cheap.

“It was too expensive at the pharmacy. I was forced to buy street drugs as they are less expensive,” he said.

Within days he was hospitalized – sickened by the very drugs that were supposed to cure him.

Tens of thousands of people in Africa die each year because of fake and counterfeit medication, an E.U.-funded report released on Tuesday said. The drugs are mainly made in China but also in India, Paraguay, Pakistan and the United Kingdom.

Almost half the fake and low-quality medicines reported to the World Health Organization (WHO) between 2013 and 2017 were found to be in sub-Saharan Africa, said the report, also backed by Interpol and the Institute for Security Studies.

A vendor writes as she stands in a legal pharmacy in Abidjan, Ivory Coast October 16, 2018. REUTERS/Luc Gnago
“Counterfeiters prey on poorer countries more than their richer counterparts, with up to 30 times greater penetration of fakes in the supply chain,” said the report.

Substandard or fake anti-malarials cause the deaths of between 64,000 and 158,000 people per year in sub-Saharan Africa, the report said.

The counterfeit drug market is worth around $200 billion worldwide annually, WHO says, making it the most lucrative trade of illegally copied goods. Its impact has been devastating.

Nigeria said more than 80 children were killed in 2009 by a teething syrup tainted with a chemical normally used in engine coolant and blamed for causing kidney failure.

For Dieng, the cost can be measured in more than simple suffering. The night in hospital cost him more than double what he would have paid had he bought the drugs the doctor ordered.

“After taking those drugs, the provenance of which we don’t know, he came back with new symptoms … All this had aggravated his condition,” said nurse Jules Raesse, who treated Dieng when he stayed at the clinic last month.

Fake drugs also threaten a thriving pharmaceutical sector in several African countries.

That has helped prompt Ivory Coast – where fake drugs were also sold openly – to crack down on the trade, estimated at $30 billion by Reuters last year.

Ivorian authorities said last month they had seized almost 400 tonnes of fake medicine over the past two years.

Able Ekissi, an inspector at the health ministry, told Reuters the seized goods, had they been sold to consumers, would have represented a loss to the legitimate pharmaceutical industry of more than $170 million.

“They are reputed to be cheaper, but at best they are ineffective and at worst toxic,” Abderrahmane Chakibi, Managing Director of French pharmaceutical firm Sanofi’s sub-Saharan Africa branch.

But in Ivory Coast, many cannot afford to shop in pharmacies, which often only stock expensive drugs imported from France, rather than cheaper generics from places like India.

“When you have no means you are forced to go out onto the street,” said Barakissa Cherik, a pharmacist in Ivory Coast’s lagoon-side commercial capital Abidjan.

https://uk.reuters.com/article/us-westafrica-drugs-fake/tens-of-thousands-die-in-africa-each-year-due-to-fake-drugs-idUKKCN1NK23I?fbclid=IwAR1mIoFEH3HjXTDXNOvF4hd_bRAp5_kup10B3pOhOP7brUS2WdguddhmHaE